The SIGMA Consortium is formed by a group of leading research institutions and Universities with extensive expertise and experience in the conduct of pharmacoepidemiologic and real-world evidence research:
Country | Institution | Lead |
Denmark | Aarhus University, Department of Clinical Epidemiology | ![]() Prof. Vera Ehrenstein |
Denmark | University of Southern Denmark, Department of Clinical Pharmacology and Pharmacy | ![]() Prof. Jesper Hallas, FISPE |
France | University of Bordeaux’s Bordeaux PharmacoEpi Platform | ![]() Dr. Cecilé Droz |
Germany | Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH | ![]() Prof. Ulrike Haug |
Italy | Agenzia Regionale di Sanità (ARS Toscana) | ![]() Dr. Rosa Gini |
Netherlands | PHARMO Institute for Drug Outcomes Research | ![]() Prof. Ron Herings, FISPE |
Netherlands | University Medical Centre Utrecht (UMCU) | ![]() Prof. Miriam Sturkenboom, FISPE |
Netherlands | Utrecht University Division of Pharmacoepidemiology & Clinical Pharmacology | ![]() Prof. Olaf Klungel |
Spain | Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) | ![]() Dr. Maria Giner |
Spain/USA | RTI Health Solutions | ![]() Dr. Susana Perez-Gutthann, FISPE |
United Kingdom | University of Dundee | ![]() Prof. Thomas MacDonald, FISPE |
The SIGMA consortium collaborates with the following research institutions:
Country | Institution | Lead |
Sweden | Karolinska Institute | Prof. Helle Kieler |
Italy | University of Verona | ![]() Dr. Gianluca Trifiró |
Italy | UNIMIB | ![]() Prof. Giampiero Mazzaglia |